CLBAX
Price
$34.19
Change
-$0.81 (-2.31%)
Updated
Dec 18 closing price
MSFHX
Price
$20.08
Change
-$0.33 (-1.62%)
Updated
Dec 18 closing price
Ad is loading...

CLBAX vs MSFHX

Header iconCLBAX vs MSFHX Comparison
Open Charts CLBAX vs MSFHXBanner chart's image
American Funds American Balanced 529A
Price$34.19
Change-$0.81 (-2.31%)
VolumeN/A
CapitalizationN/A
MFS Total Return R3
Price$20.08
Change-$0.33 (-1.62%)
VolumeN/A
CapitalizationN/A
CLBAX vs MSFHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBAX vs. MSFHX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a Hold and MSFHX is a Hold.

FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 241B vs. MSFHX (7.88B). MSFHX (2.31) and CLBAX (2.23) have matching dividends . CLBAX was incepted earlier than MSFHX: CLBAX (23 years) vs MSFHX (20 years). CLBAX is a more actively managed with annual turnover of: 171.00 vs. MSFHX (43.00). MSFHX has a lower initial minimum investment than CLBAX: MSFHX (0) vs CLBAX (250). CLBAX annual gain was more profitable for investors over the last year : 12.51 vs. MSFHX (6.11). CLBAX return over 5 years is better than : 34.39 vs. MSFHX (12.88).
CLBAXMSFHXCLBAX / MSFHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years20 years-
Gain YTD11.5238.946129%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets241B7.88B3,057%
Annual Yield % from dividends2.232.3197%
Returns for 1 year12.516.11205%
Returns for 3 years13.212.68494%
Returns for 5 years34.3912.88267%
Returns for 10 years58.6633.76174%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALEX18.65-0.21
-1.11%
Alexander & Baldwin
CAR89.17-1.62
-1.78%
Avis Budget Group
WAB198.19-4.11
-2.03%
Wabtec
KIRK1.79-0.04
-2.19%
Kirkland's
LRMR4.32-0.51
-10.56%
Larimar Therapeutics